Acesso livre
Acesso livre

Clínica Médica

M-A de estudos randomizados | Associação entre intensidade da redução do LDL-colesterol com terapias baseadas em estatinas e prevenção secundária de AVC.

22 Fev, 2022 | 15:24h

Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials – JAMA Neurology

Editorial: Low-Density Lipoprotein Cholesterol Level After a Stroke—Reducing It by Any Means (gratuito por tempo limitado)


M-A | Características diagnósticas, tratamento e prognóstico do infarto do miocárdio tipo 2 em comparação ao tipo 1.

22 Fev, 2022 | 15:23h

Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis – BMJ Open


Síncope de início precoce e tardio: compreensão do mecanismo.

22 Fev, 2022 | 15:19h

Early and late-onset syncope: insight into mechanisms – European Heart Journal

 

Comentário no Twitter

 


Análise de especialista | Pré-excitação ventricular assintomática (padrão Wolff-Parkinson-White): quando se preocupar.

22 Fev, 2022 | 15:09h

Asymptomatic Ventricular Preexcitation (Wolff-Parkinson-White Pattern): When to Be Concerned – American College of Cardiology


Revisão sistemática atualizada e metanálise dose-resposta de estudos de coorte prospectiva | Carboidratos da dieta e risco de diabetes tipo 2.

22 Fev, 2022 | 15:07h

Dietary carbohydrate and the risk of type 2 diabetes: an updated systematic review and dose–response meta-analysis of prospective cohort studies – Scientific Reports


Estudo randomizado | Em pacientes com Covid-19 leve a moderada e comorbidades, o tratamento com ivermectina não reduziu o risco de progressão da doença.

22 Fev, 2022 | 14:55h

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial – JAMA Internal Medicine

Comentários:

Ivermectin doesn’t prevent severe disease from Covid-19, new study finds – CNN

Ivermectin futile for mild to moderate COVID-19, study finds – CIDRAP

Conteúdos relacionados:

Case Series: Toxic effects from ivermectin use associated with prevention and treatment of Covid-19.

Long-term consequences of the misuse of ivermectin data.

Ivermectin: How false science created a Covid ‘miracle’ drug.

Fraudulent ivermectin studies open up new battleground between science and misinformation.

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Ivermectin: Cochrane’s most talked about review so far, ever. Why?

Flawed ivermectin preprint highlights challenges of COVID drug studies.

Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

Why was a major study on ivermectin for covid-19 just retracted?

RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”.

Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19


Diretrizes rápidas da ESCMID para avaliação e tratamento de “long COVID”.

22 Fev, 2022 | 14:52h

ESCMID rapid guidelines for assessment and management of long COVID – Clinical Microbiology and Infection

Conteúdos relacionados:

ERS statement on Long COVID-19 follow-up.

Proposed subtypes of long-Covid and their respective potential therapies.

EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)


Revisão | “Long COVID”: sequelas pós-agudas de COVID-19 com foco cardiovascular.

22 Fev, 2022 | 14:49h

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus – European Heart Journal

Comunicado de imprensa: Review highlights impact of Long COVID on cardiovascular system – University of Oxford

Conteúdos relacionados:

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.


Estudo randomizado | Aconselhamento de pacientes com sobrepeso para aumentarem a duração do sono pode reduzir a ingestão calórica.

22 Fev, 2022 | 14:46h

Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial – JAMA Internal Medicine

Comunicado de imprensa: Getting more sleep reduces caloric intake, a game changer for weight loss programs – University of Chicago Medical Center

Comentários:

Cut nearly 300 calories a day by doing something you already do – CNN

Individualized Sleep Counseling Can Aid Weight Loss in Overweight – HealthDay

 

Comentário no Twitter

 


Diretriz de consenso ERAS/SVS sobre cuidado perioperatório em cirurgia vascular aórtica aberta.

22 Fev, 2022 | 14:43h

Perioperative care in open aortic vascular surgery: A Consensus Statement by the Enhanced Recovery after Surgery (ERAS®) Society and Society for Vascular Surgery – Journal of Vascular Surgery


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.